Global Neurovascular Devices or Interventional Neurology Market, by Products,
Global Neurovascular Devices or Interventional Neurology Market, by End-Users,
Global Neurovascular Devices or Interventional Neurology Market, by Region,
North America Neurovascular Devices or Interventional Neurology Market, by Country,
Europe Neurovascular Devices or Interventional Neurology Market, by Country,
Asia Pacific Neurovascular Devices or Interventional Neurology Market, by Country,
Latin America Neurovascular Devices or Interventional Neurology Market, by Country,
Middle East & Africa Neurovascular Devices or Interventional Neurology Market, by Country,
Competitive Landscape
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neurovascular Devices/Interventional Neurology Market Snapshot
Chapter 4. Global Neurovascular Devices/Interventional Neurology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter’s Five Forces Analysis
4.6. Competitive Landscape & Market Share Analysis
4.7. Clinical Trial/Pipeline Analysis
4.8. COVID 19 Impact Analysis
Chapter 5. Neurovascular Devices/Interventional Neurology Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2024 & 2034
5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products:
5.2.1. Aneurysm Coiling & Embolization Devices
5.2.1.1. Embolic Coils
5.2.1.1.1. Bare Detachable Coils
5.2.1.1.2. Coated Detachable Coils
5.2.1.2. Flow Diversion Devices
5.2.1.3. Liquid Embolic Agents
5.2.2. Cerebral Balloon Angioplasty & Stenting Systems
5.2.2.1. Carotid Artery Stents
5.2.2.2. Embolic Protection Devices
5.2.2.3. Balloon Catheters
5.2.3. Support Devices
5.2.3.1. Microcatheters
5.2.3.2. Guidewires
5.2.4. Neurothrombectomy devices
5.2.4.1. Clot Retrievals
5.2.4.2. Suction & Aspiration Devices
5.2.4.3. Snares
Chapter 6. Neurovascular Devices/Interventional Neurology Market Segmentation 2: By End-Users Estimates & Trend Analysis
6.1. By End-Users Analysis & Market Share, 2024 & 2034
6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
6.2.1. Hospitals & surgical centers
6.2.2. Ambulatory care centers
6.2.3. Research laboratories & academic institutes
Chapter 7. Neurovascular Devices/Interventional Neurology Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2021-2034
7.1.2. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2021-2034
7.1.3. North America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034
7.2.2. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2021-2034
7.2.3. Europe Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034
7.3.2. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2021-2034
7.3.3. Asia Pacific Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034
7.4.2. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
7.4.3. Latin America Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034
7.5.2. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) By End-Users, (US$ Million) 2021-2034
7.5.3. MEA revenue Neurovascular Devices/Interventional Neurology Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034
7.5.3.1. South Africa
7.5.3.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Johnson & Johnson (US)
8.2.2. Medtronic PLC (Ireland)
8.2.3. Stryker Corporation (US)
8.2.4. Terumo Corporation (Japan)
8.2.5. Penumbra, Inc. (US)
8.2.6. Microport Scientific Corporation (China)
8.2.7. Kaneka Corp. (Japan)
8.2.8. Integer Holdings Corporation
8.2.9. Balt (France)
8.2.10. Perflow Medical
8.2.11. Phenox GmbH (Germany)
8.2.12. Sensome (France)
8.2.13. Evasc (Canada)
8.2.14. Rapid Medical (Israel)
8.2.15. Asahi Intecc Co. Ltd (Japan)
8.2.16. Acandis GmbH (Germany)
8.2.17. Medikit Co. Ltd (Japan)
8.2.18. Imperative Care (US)
8.2.19. Lepu Medical (China)
8.2.20. Cerus Endovascular (US)
8.2.21. MicroVention, Inc.
8.2.22. Mizuho Medical
8.2.23. Peter Lazic GmBH
8.2.24. Spartan Micro
8.2.25. Emboflu
8.2.26. Straub Medical AG
8.2.27. AngioDynamics
8.2.28. Stryker Corporation
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.